A prenatal trisomy 21 screening program using α-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood
- 31 January 1995
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 172 (1) , 167-174
- https://doi.org/10.1016/0002-9378(95)90108-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Non-radioactive assay of AFP, hCG, and uE3 from dried blood specimens: A low-cost alternative for maternal screening for trisomy 21Prenatal Diagnosis, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- hCG, AFP, and uE3 patterns in the 14–20th weeks of Down's syndrome pregnanciesPrenatal Diagnosis, 1992
- Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analysesPrenatal Diagnosis, 1992
- The efficacy of maternal age screening for Down's syndrome in WessexPrenatal Diagnosis, 1991
- Maternal serum markers in screening for Down syndromeClinical Genetics, 1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein levelBJOG: An International Journal of Obstetrics and Gynaecology, 1987